Cardiovascular Disease in Pregnancy Part IV: Pulmonary Hypertension, Marfan's, and Bicuspid Aortic Valve

Pulmonary Hypertension 

  • What is PH? 

    • Elevation in mean pulmonary arterial pressure (PAP) >/= 25 mmHg upon right heart catheterization 

    • PAH or pulmonary arterial hypertension = subset of PH characterized by LV filling pressure </= 15 mmHg and a pulmonary vascular resistance > 3 Wood Units 

    • Why is it important in pregnancy? 

      • Mortality remains high in women with PH (9-28% mortality) 

      • There is a recommendation to avoid pregnancy, and termination should be discussed 

      • Greatest risk = during labor and immediately postpartum 

      • Causes of death most commonly are pulmonary hypertensive crisis, pulmonary thrombosis, and right heart failure 

    • What to do if they get pregnant

      • Echocardiography to evaluate heart function 

      • Right heart catheterization is recommended if diagnostic uncertainty 

      • Multidisciplinary team to care for mother in a tertiary care center 

      • Consider anticoagulation as thrombo-embolism is a major risk 

      • Diuretics if heart failure 

    • Delivery 

      • Multidisciplinary delivery team 

      • Vaginal delivery can be associated with volume changes during contractions → can pose a problem to women with pulmonary hypertension because they have a limited capability to increase their cardiac output 

      • Remember: cardiac output increases 30% in first stage of labor and >50% in second stage of labor 

      • Planned cesarean may be a better choice - but we need to monitor hemodynamic arterial and central venous pressure

      • Postpartum - also need to observe closely due to fluid shifts. Continue to record strict I/Os and optimize RV function

  • Marfan’s Syndrome 

    • Overall risk is aortic dissection associated with pregnancy → ~3% 

    • Aortic size is a major determinant of risk, but even women with aortic root of <40 mm, risk of dissection is 1% 

    • Pregnancy should be avoided in Marfans if aortic root is >45 mm → increased risk of dissection 

    • If 40-45mm, other factors like rate of growth and family history should be considered 

  • Bicuspid Aortic Valve 

    • Can also lead to aortic dilatation; occurs in less than 50% of patients with a bicuspid aortic valve 

    • The dilatation can be in the distal ascending aorta which cannot be seen well with echo 

    • Risk of dissection is overall small, but pregnancy should be avoided if aorta diameter is >50 mm 

  • General considerations in the antepartum 

    • Testing for mom 

      • EKG 

      • Echo - with unexplained or new cardiovascular signs or symptoms, or known cardiac disease in pregnancy 

      • Exercise testing 

      • Other tests 

    • Genetic testing and counseling 

      • Prepregnancy counseling of course, and risk assessment with the mWHO classification of maternal risk 

      • High risk patients should be treated by a multidisciplinary pregnancy heart team  

      • Genetic counseling should be considered if congenital heart disease or congenital arrhythmias, cardiomyopathies, aortic disease, or genetic malformation associated with CVD 

        • Why? Increased risk of fetal congenital heart disease in moms with these issues (baseline 1% goes up to 3-5%) 

    • Labor and delivery

      • Vaginal delivery is generally recommended as first choice for most patients unless the have the following, at which point cesarean should be considered: 

        • Dilatation of the ascending aorta >45 mm, severe aortic stenosis, preterm labor while on oral anticoagulants, PH, Eisenmenger’s syndrome, or severe heart failure 

      • IOL should be considered by 40 weeks at the latest 

      • Postpartum: discussion of birth control and prevention of next pregnancy 

      • Postpartum testing of maternal cardiac status 

    • Fetal assessment 

      • Fetal echo when there is an elevated risk of fetal abnormalities 

      • Consideration of growth ultrasounds as there is higher risk of FGR 

      • Consideration of fetal testing